Nicotine use in schizophrenia: the self medication hypotheses.
paper
Cited
Public
Unavailable
- Authors
- Kumari, Veena; Postma, Peggy
- Year
- 2005
- Journal
- Neuroscience and biobehavioral reviews
- PMID
- 15964073
- DOI
- 10.1016/j.neubiorev.2005.02.006
The behavioural and cognitive effects of nicotine in schizophrenia have received much interest in recent years. The rate of smoking in patients with schizophrenia is estimated to be two- to four-fold the rate seen in the general population. Furthermore such patients favour stronger cigarettes and may also extract more nicotine from their cigarettes than other smokers. The question has been raised whether the widespread smoking behaviour seen in this patient group is in fact a manifestation of a common underlying physiology, and that these patients smoke in an attempt to self-medicate. We present an overview of the explanations for elevated rates of smoking in schizophrenia, with particular emphasis on the theories relating this behaviour to sensory gating and cognitive deficits in this disorder that have been viewed as major support for the self-medication hypotheses.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. | 2017 | 28739213 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Moderating Role of Cigarette Smoking on the Efficacy of tDCS in the Treatment of Negative and Cognitive Symptoms of Schizophrenia: Results from a Randomized Clinical Trial. | Lisoni J et al. | β | 2026 | β |
| Novel drug treatments for schizophrenia. | Coyle JT et al. | β | 2026 | β |
| The Effect of Smoking Cigarettes on the Progression of Psychotic Experiences to Psychotic Disorder: Evidence From a 6-Year Follow-Up Study. | GΓΌvercin E et al. | β | 2026 | β |
| Circadian rhythmicity in prepulse inhibition of the acoustic startle response: A study of chronotype and time-of-day effects in young healthy adults. | Chauhan S et al. | β | 2025 | β |
| Clearing the smoke: experiences of patients and professionals during a one-year smoking cessation intervention in ambulatory mental healthcare - a qualitative study. | Küçükaksu MH et al. | β | 2025 | β |
| Does the Path From Cigarette Smoking to Suicide Death Go Through the Hospital? A Causal Mediation Analysis in a National Canadian Sample. | Balbuena L et al. | β | 2025 | β |
| From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes. | PΓ©rez-Ramos A et al. | β | 2025 | β |
| Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective. | Sinkevicius LV et al. | β | 2025 | β |
| Nucleus Accumbens Proteome Disbalance in an Adolescent Mouse Model of Schizophrenia and Nicotine Misuse Comorbidity. | Souza TP et al. | β | 2025 | β |
| Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia. | Trubalski M et al. | β | 2025 | β |
| Psychological side effects of antipsychotic medication after remission from first-episode psychosis: a HAMLETT ecological momentary assessment study. | Djordjevic M et al. | β | 2025 | β |
| Smoking and its associations with metabolic indices, clinical symptoms, and cognitive functioning in schizophrenia. | Liu J et al. | β | 2025 | β |
| Smoking prevalence and correlates among inpatients with schizophrenia or schizoaffective disorder. | Wu C et al. | β | 2025 | β |
| The Association Between Chronic Tobacco Smoking and Brain Alterations in Schizophrenia: A Systematic Review of Magnetic Resonance Imaging Studies. | Koster M et al. | β | 2025 | β |
| A reduction in cigarette smoking improves health-related quality of life and does not worsen psychiatric symptoms in individuals with serious mental illness. | Brady DJ et al. | β | 2024 | β |
| Establishing associated risk factors, including fungal and parasitic infections among Malaysians living with schizophrenia. | Franklin F et al. | β | 2024 | β |
| Genetic components of microdeletion syndromes and their role in determining schizophrenia traits. | Biswal SR et al. | β | 2024 | β |
| Investigating the Impacts of Diet, Supplementation, Microbiota, Gut-Brain Axis on Schizophrenia: A Narrative Review. | Zajkowska I et al. | β | 2024 | β |
| Nicotine's Effects on Schizophrenia-like Symptoms in a Mice Model: Time Matters. | Dutra-Tavares AC et al. | β | 2024 | β |
| Smoking behavior is associated with suicidality in individuals with psychosis and bipolar disorder: a systematic quantitative review and meta-analysis. | Pietschnig J et al. | β | 2024 | β |
| Smoking in patients with schizophrenia: Prevalence rate and connections with cognitive functions, psychiatric symptoms, and clinical and demographic characteristics | Wu C et al. | β | 2024 | β |
| Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic. | Bennett CW et al. | β | 2023 | β |
| A smoking cessation intervention for people with severe mental illness treated in ambulatory mental health care (KISMET): study protocol of a randomised controlled trial. | Küçükaksu MH et al. | β | 2023 | β |
| A systematic review of digital interventions for smoking cessation in patients with serious mental illness. | Martinez Agulleiro L et al. | β | 2023 | β |
| Genetic susceptibility for schizophrenia after adjustment by genetic susceptibility for smoking: implications in identification of risk genes and genetic correlation with related traits. | Al-Soufi L et al. | β | 2023 | β |
| Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice. | RodrΓguez-Vega A et al. | β | 2023 | β |
| Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial. | Sinichi F et al. | β | 2023 | β |
| Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders. | Sakinyte K et al. | β | 2023 | β |
| Adolescent nicotine potentiates the inhibitory effect of raclopride, a D<sub>2</sub>R antagonist, on phencyclidine-sensitized psychotic-like behavior in mice. | Dutra-Tavares AC et al. | β | 2022 | β |
| An evaluation of the feasibility of implementing a novel tobacco dependence treatment program for high-risk individuals into clinical practice within a community mental health center. | Hogan TH et al. | β | 2022 | β |
| Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study. | Malandain L et al. | β | 2022 | β |
| A polygenic approach to the association between smoking and schizophrenia. | Al-Soufi L et al. | β | 2022 | β |
| Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder. | Koevoet D et al. | β | 2022 | β |
| Developing a Smoking Cessation Intervention for People With Severe Mental Illness Treated by Flexible Assertive Community Treatment Teams in the Netherlands: A Delphi Study. | Küçükaksu MH et al. | β | 2022 | β |
| Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence. | Ward HB et al. | β | 2022 | β |
| Impact of smoking bans and other smoking cessation interventions in prisons, mental health and substance use treatment settings: A systematic review of the evidence. | Sourry RJ et al. | β | 2022 | β |
| Smoking Addiction in Patients with Schizophrenia Spectrum Disorders and Its Perception and Intervention in Healthcare Personnel Assigned to Psycho-Rehabilitation Programs: A Qualitative Research. | Caponnetto P et al. | β | 2022 | β |
| Smoking cessation among people with mental illness: A South African perspective. | Morar T et al. | β | 2022 | β |
| The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders. | Eickhoff S et al. | β | 2022 | β |
| Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal study. | van der Heijden HS et al. | β | 2021 | β |
| DNA methylome perturbations: an epigenetic basis for the emergingly heritable neurodevelopmental abnormalities associated with maternal smoking and maternal nicotine exposureβ . | Buck JM et al. | β | 2021 | β |
| Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model. | Dutra-Tavares AC et al. | β | 2021 | β |
| Effects of 7.5% Carbon Dioxide and Nicotine Administration on Latent Inhibition. | Granger KT et al. | β | 2021 | β |
| Evaluation of IGF-1 as a novel theranostic biomarker for schizophrenia. | Yesilkaya UH et al. | β | 2021 | β |
| Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium. | Peterson RE et al. | β | 2021 | β |
| Multiple nicotinic acetylcholine receptor subtypes regulate social or cognitive behaviors in mice repeatedly administered phencyclidine. | Noda Y et al. | β | 2021 | β |
| Nicotine Administration Normalizes Behavioral and Neurophysiological Perturbations in the MAM Rodent Model of Schizophrenia. | Weeks JJ et al. | β | 2021 | β |
| Prospective, observational, single-centre cohort study with an independent control group matched for age and sex aimed at investigating the significance of cholinergic activity in patients with schizophrenia: study protocol of the CLASH-study. | Schick B et al. | β | 2021 | β |
| Schizotypy, Lifestyle Behaviors, and Health Indicators in a Young Adult Sample. | Dinzeo TJ et al. | β | 2021 | β |
| Smoking and drinking among patients with mental disorders: Evidence from a nationally representative Japanese survey. | Okubo R et al. | β | 2021 | β |
| Smoking as a Common Modulator of Sensory Gating and Reward Learning in Individuals with Psychotic Disorders. | Whitton AE et al. | β | 2021 | β |
| The Association between Lifestyle Choices and Schizophrenia Symptoms. | Kalinowska S et al. | β | 2021 | β |
| A meta-analysis of craving studies in schizophrenia spectrum disorders. | DondΓ© C et al. | β | 2020 | β |
| An examination of factors associated with tobacco smoking amongst patients presenting with deliberate self-poisoning. | Murray EG et al. | β | 2020 | β |
| Association between polygenic liability for schizophrenia and substance involvement: A nationwide population-based study in Taiwan. | Wang SH et al. | β | 2020 | β |
| Characteristics of Chinese smokers with psychotic disorders and their predictors on smoking cessation in Hong Kong. | Ho RKS et al. | β | 2020 | β |
| Cholinergic Receptors and Addiction. | Papke RL et al. | β | 2020 | β |
| Chronic smoking and cognition in patients with schizophrenia: A meta-analysis. | Coustals N et al. | β | 2020 | β |
| Deciphering midbrain mechanisms underlying prepulse inhibition of startle. | Fulcher N et al. | β | 2020 | β |
| Experiences of Tobacco Use among Chinese Individuals with Schizophrenia in Community-Based Residential Settings: A Qualitative Study. | Mak YW et al. | β | 2020 | β |
| Genetic Determinants of Gating Functions: Do We Get Closer to Understanding Schizophrenia Etiopathogenesis? | RovnΓ½ R et al. | β | 2020 | β |
| Increased dopamine availability magnifies nicotine effects on cognitive control: A pilot study. | Ahrens S et al. | β | 2020 | β |
| Internet gaming as a coping method among schizophrenic patients facing psychological distress. | Chang YH et al. | β | 2020 | β |
| Nicotinic Acetylcholine Receptor Density in the "Higher-Order" Thalamus Projecting to the Prefrontal Cortex in Humans: a PET Study. | Garibotto V et al. | β | 2020 | β |
| Polygenic risk scores for late smoking initiation associated with the risk of schizophrenia. | Ohi K et al. | β | 2020 | β |
| Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence. | Konjevod M et al. | β | 2020 | β |
| Tobacco smoking, related harm and motivation to quit smoking in people with schizophrenia spectrum disorders. | Caponnetto P et al. | β | 2020 | β |
| Worldwide prevalence of smoking cessation in schizophrenia patients: A meta-analysis of comparative and observational studies. | Zeng LN et al. | β | 2020 | β |
| Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia. | Tregellas JR et al. | β | 2019 | β |
| Chronic nicotine administration restores brain region specific upregulation of oxytocin receptor binding levels in a G72 mouse model of schizophrenia. | Zanos P et al. | β | 2019 | β |
| Cognitive functions in smoking and non-smoking patients with schizophrenia: A systematic review and meta-analysis of comparative studies. | Wang YY et al. | β | 2019 | β |
| Combining CDP-choline and galantamine, an optimized Ξ±7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia. | Choueiry J et al. | β | 2019 | β |
| Combining CDP-choline and galantamine: Effects of a selective Ξ±7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers. | Choueiry J et al. | β | 2019 | β |
| Density of small dendritic spines and microtubule-associated-protein-2 immunoreactivity in the primary auditory cortex of subjects with schizophrenia. | McKinney BC et al. | β | 2019 | β |
| Effects of nicotine on smooth pursuit eye movements in healthy non-smokers. | MeyhΓΆfer I et al. | β | 2019 | β |
| Effects of Tobacco Smoking Status on Verbal Learning and Memory in Patients With Schizophrenia and Non-Psychiatric Controls. | Kozak K et al. | β | 2019 | β |
| Focus on the pedunculopontine nucleus. Consensus review from the May 2018 brainstem society meeting in Washington, DC, USA. | Garcia-Rill E et al. | β | 2019 | β |
| Genome-Wide Variants Shared Between Smoking Quantity and Schizophrenia on 15q25 Are Associated With CHRNA5 Expression in the Brain. | Ohi K et al. | β | 2019 | β |
| Motivations to quit smoking and challenges faced during cessation among individuals with first episode psychosis in Singapore. | Sagayadevan V et al. | β | 2019 | β |
| Nicotine dependence in community-dwelling Chinese patients with schizophrenia. | Li Y et al. | β | 2019 | β |
| Nicotine excites VIP interneurons to disinhibit pyramidal neurons in auditory cortex. | Askew CE et al. | β | 2019 | β |
| Preservation Effect: Cigarette Smoking Acts on the Dynamic of Influences Among Unifying Neuropsychiatric Triple Networks in Schizophrenia. | Liao W et al. | β | 2019 | β |
| Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia: Systematic review and meta-analysis of comparative studies. | Huang H et al. | β | 2019 | β |
| The relationship between nicotine and psychosis. | Quigley H et al. | β | 2019 | β |
| Use of tobacco in schizophrenia: A double-edged sword. | Fang Y et al. | β | 2019 | β |
| Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach. | Hu Y et al. | β | 2018 | β |
| Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study. | Aidelbaum R et al. | β | 2018 | β |
| Lessons and Guidance from the Special Issue on Electronic Cigarette Use and Public Health. | Sumner W et al. | β | 2018 | β |
| Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia. | Boggs DL et al. | β | 2018 | β |
| Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning. | Milienne-Petiot M et al. | β | 2018 | β |
| The wonderland of neuronal nicotinic acetylcholine receptors. | Bertrand D et al. | β | 2018 | β |
| Tobacco smoking and its association with cognition in first episode psychosis patients. | Hickling LM et al. | β | 2018 | β |
| Tobacco smoking is associated with psychotic experiences in the general population of South London. | Bhavsar V et al. | β | 2018 | β |
| A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions. | Feng M et al. | β | 2017 | β |
| Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. | Hartz SM et al. | β | 2017 | β |
| Association of social support and quality of life among people with schizophrenia receiving community psychiatric service: A cross-sectional study. | Munikanan T et al. | β | 2017 | β |
| Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis. | Carney R et al. | β | 2017 | β |
| Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic Ξ±<sub>4</sub>Ξ²<sub>2</sub>-receptor partial agonist varenicline. | Batsikadze G et al. | β | 2017 | β |
| Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review. | Howells FM et al. | β | 2017 | β |
| Effects of nicotine on response inhibition and interference control. | Ettinger U et al. | β | 2017 | β |
| Green tea effects on cognition, mood and human brain function: A systematic review. | Mancini E et al. | β | 2017 | β |
| Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life. | Li XH et al. | β | 2017 | β |
| Quality of life in Chinese patients with schizophrenia treated in primary care. | Li Y et al. | β | 2017 | β |
| Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis. | Grossman M et al. | β | 2017 | β |
| Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging. | Smucny J et al. | β | 2017 | β |
| Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial. | Jeon DW et al. | β | 2016 | β |
| Age at first tobacco use and risk of subsequent psychosis-related outcomes: A birth cohort study. | McGrath JJ et al. | β | 2016 | β |
| A Reasonable Alternative to Clozapine in the Chronically Relapsing Smoking Patient? A Retrospective Analysis. | Tomko JR et al. | β | 2016 | β |
| Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis. | Carney R et al. | β | 2016 | β |
| Cigarette smoking, nicotine dependence, and motivation to quit smoking in South African male psychiatric inpatients. | Du Plooy JL et al. | β | 2016 | β |
| Current cigarette smoking in Chinese female patients with schizophrenia: A meta-analysis. | Cao XL et al. | β | 2016 | β |
| Differential effects of sex on substance use between first episode psychosis patients and healthy people. | NΓΊΓ±ez C et al. | β | 2016 | β |
| Effects of the phencyclidine model of schizophrenia and nicotine on total and categorized ultrasonic vocalizations in rats. | Swalve N et al. | β | 2016 | β |
| Genetic Relationship between Schizophrenia and Nicotine Dependence. | Chen J et al. | β | 2016 | β |
| Mismatch responses and deviance detection in N-methyl-D-aspartate (NMDA) receptor hypofunction and developmental models of schizophrenia. | Harms L | β | 2016 | β |
| nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. | Parikh V et al. | β | 2016 | β |
| Nicotine ameliorates schizophrenia-like cognitive deficits induced by maternal LPS exposure: a study in rats. | Waterhouse U et al. | β | 2016 | β |
| Reducing smoking reduces suicidality among individuals with psychosis: Complementary outcomes from a Healthy Lifestyles intervention study. | Sankaranarayanan A et al. | β | 2016 | β |
| Schizophrenia, smoking status, and performance on the matrics Cognitive Consensus Battery. | Reed AC et al. | β | 2016 | β |
| Smoking and Serum Lipid Profiles in Schizophrenia. | An HM et al. | β | 2016 | β |
| Smoking in male patients with schizophrenia in China: A meta-analysis. | Li Y et al. | β | 2016 | β |
| State Clean Indoor Air Laws and smoking among adults with poor mental health. | Larson A et al. | β | 2016 | β |
| Substance use associated with short sleep duration in patients with schizophrenia or schizoaffective disorder. | Tang VK et al. | β | 2016 | β |
| Targeting Functional Biomarkers in Schizophrenia with Neuroimaging. | Wylie KP et al. | β | 2016 | β |
| Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder. | Vrana SR et al. | β | 2015 | β |
| A functional polymorphism in the interleukin-1beta and severity of nicotine dependence in male schizophrenia: a case-control study. | Zhang XY et al. | β | 2015 | β |
| Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats. | Swalve N et al. | β | 2015 | β |
| Cognitive enhancing agents in schizophrenia and bipolar disorder. | Vreeker A et al. | β | 2015 | β |
| COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokers. | Bowers H et al. | β | 2015 | β |
| Does chronic nicotine consumption influence visual backward masking in schizophrenia and schizotypy? | Shaqiri A et al. | β | 2015 | β |
| Does tobacco use cause psychosis? Systematic review and meta-analysis. | Gurillo P et al. | β | 2015 | β |
| Drug Addiction in Patients With Chronic Schizophrenia and Its Relation With Psychopathology and Impulsiveness. | Shokrgozar S et al. | β | 2015 | β |
| Effects of sleep deprivation on inhibitory biomarkers of schizophrenia: implications for drug development. | Ettinger U et al. | β | 2015 | β |
| Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms. | Chien YL et al. | β | 2015 | β |
| Examining the reinforcement-enhancement effects of phencyclidine and its interactions with nicotine on lever-pressing for a visual stimulus. | Swalve N et al. | β | 2015 | β |
| Inhibitory learning is modulated by nicotinic acetylcholine receptors. | Meyer HC et al. | β | 2015 | β |
| Mental health starts with physical health: current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis. | Gates J et al. | β | 2015 | β |
| Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers. | Knott V et al. | β | 2015 | β |
| Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders. | Terry AV et al. | β | 2015 | β |
| [Psychoeducational Smoking Cessation Groups in an Acute Psychiatry Ward]. | Fugger G et al. | β | 2015 | β |
| Resting-state functional connectivity and nicotine addiction: prospects for biomarker development. | Fedota JR et al. | β | 2015 | β |
| Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study. | Zhang XY et al. | β | 2015 | β |
| Smoking cessation and reduction in people with chronic mental illness. | Tidey JW et al. | β | 2015 | β |
| Smoking in schizophrenia: cognitive impact of nicotine and relationship to smoking motivators. | Beck AK et al. | β | 2015 | β |
| Smoking in schizophrenic patients: A critique of the self-medication hypothesis. | Manzella F et al. | β | 2015 | β |
| Smoking, Suicidality and Psychosis: A Systematic Meta-Analysis. | Sankaranarayanan A et al. | β | 2015 | β |
| [Strong association between nicotine dependence symptoms and Cluster A personality disorder traits]. | Laconi S et al. | β | 2015 | β |
| Targeting of Ξ±7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker. | Hashimoto K | β | 2015 | β |
| The separate and combined effects of monoamine oxidase A inhibition and nicotine on the mismatch negativity event related potential. | Smith DM et al. | β | 2015 | β |
| The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating. | Smith DM et al. | β | 2015 | β |
| Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study. | Zhu W et al. | β | 2014 | β |
| Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations. | Herzig DA et al. | β | 2014 | β |
| Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study. | Wijesundera H et al. | β | 2014 | β |
| Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children. | Gage SH et al. | β | 2014 | β |
| CDP-choline: effects of the procholine supplement on sensory gating and executive function in healthy volunteers stratified for low, medium and high P50 suppression. | Knott V et al. | β | 2014 | β |
| Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task. | Scott D et al. | β | 2014 | β |
| Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia. | Hambsch B et al. | β | 2014 | β |
| Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. | Ashare RL et al. | β | 2014 | β |
| Delay discounting and task performance consistency in patients with schizophrenia. | Weller RE et al. | β | 2014 | β |
| Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats. | Jones KM et al. | β | 2014 | β |
| Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. | Mathalon DH et al. | β | 2014 | β |
| Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats. | Levin ED et al. | β | 2014 | β |
| EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. | RΓΌther T et al. | β | 2014 | β |
| Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood. | DeAngeli NE et al. | β | 2014 | β |
| Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention. | Filia SL et al. | β | 2014 | β |
| Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. | Boggs DL et al. | β | 2014 | β |
| Mismatch negativity latency and cognitive function in schizophrenia. | KΓ€rgel C et al. | β | 2014 | β |
| Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study. | Knott V et al. | β | 2014 | β |
| Nicotine exposure during adolescence: cognitive performance and brain gene expression in adult heterozygous reeler mice. | Romano E et al. | β | 2014 | β |
| Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapy. | Xu YM et al. | β | 2014 | β |
| Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population. | Zhang XY et al. | β | 2014 | β |
| The case in favor of E-cigarettes for tobacco harm reduction. | Nitzkin JL | β | 2014 | β |
| The relationship between serum brain-derived neurotrophic factor (BDNF) and cardiometabolic indices in schizophrenia. | Nurjono M et al. | β | 2014 | β |
| Tobacco smoking in schizophrenia: investigating the role of incentive salience. | Freeman TP et al. | β | 2014 | β |
| Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective. | Quednow BB et al. | β | 2014 | β |
| Altered contextual modulation of primary visual cortex responses in schizophrenia. | Seymour K et al. | β | 2013 | β |
| Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study. | Zhang XY et al. | β | 2013 | β |
| Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings. | Thoma P et al. | β | 2013 | β |
| Effects of acute nicotine on prepulse inhibition of auditory change-related cortical responses. | Kodaira M et al. | β | 2013 | β |
| Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors. | de la Salle S et al. | β | 2013 | β |
| Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. | Drusch K et al. | β | 2013 | β |
| Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. | Schmechtig A et al. | β | 2013 | β |
| Evaluation of smoking status identification using electronic health records and open-text information in a large mental health case register. | Wu CY et al. | β | 2013 | β |
| Genetic dissection of medial habenula-interpeduncular nucleus pathway function in mice. | Kobayashi Y et al. | β | 2013 | β |
| In patients with schizophrenia, non-fatal suicidal self-directed violence is positively associated with present but not past smoking. | Kanwar J et al. | β | 2013 | β |
| Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings. | SΓ‘nchez-Torres AM et al. | β | 2013 | β |
| Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal. | Dani JA et al. | β | 2013 | β |
| Neuropsychological functioning and age-related changes in schizophrenia and/or cocaine dependence. | Benaiges I et al. | β | 2013 | β |
| Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice. | Romano E et al. | β | 2013 | β |
| Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test. | Young JW et al. | β | 2013 | β |
| Novel approaches to drug design for the treatment of schizophrenia. | Taly A | β | 2013 | β |
| Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders. | Thornton LK et al. | β | 2013 | β |
| Persistent gene expression changes in NAc, mPFC, and OFC associated with previous nicotine or amphetamine exposure. | Mychasiuk R et al. | β | 2013 | β |
| Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. | Acheson DT et al. | β | 2013 | β |
| Sensorimotor gating and spatial learning in Ξ±7-nicotinic receptor knockout mice. | Azzopardi E et al. | β | 2013 | β |
| Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine. | Uchiumi O et al. | β | 2013 | β |
| The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. | Grayson DR et al. | β | 2013 | β |
| The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism. | Petrovsky N et al. | β | 2013 | β |
| Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment. | Iasevoli F et al. | β | 2013 | β |
| Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia. | Velligan D et al. | β | 2012 | β |
| Can genetics inform the management of cognitive deficits in schizophrenia? | Vyas NS et al. | β | 2012 | β |
| Mental health nurses' attitudes towards the physical health care of people with severe and enduring mental illness: the development of a measurement tool. | Robson D et al. | β | 2012 | β |
| Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. | Stephens SH et al. | β | 2012 | β |
| Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait. | Knott V et al. | β | 2012 | β |
| Nicotine dependence and illness severity in schizophrenia. | Krishnadas R et al. | β | 2012 | β |
| Reasons for substance use among people with mental disorders. | Thornton LK et al. | β | 2012 | β |
| The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. | Terry AV et al. | β | 2012 | β |
| Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. | Cooper J et al. | β | 2012 | β |
| Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice. | Umezu T | β | 2012 | β |
| ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. | Chen J et al. | β | 2011 | β |
| Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study. | MacKillop J et al. | β | 2011 | β |
| Cigarette smoking in community-dwelling patients with schizophrenia in China. | Hou YZ et al. | β | 2011 | β |
| Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. | Segarra R et al. | β | 2011 | β |
| Delayed procedural learning in Ξ±7-nicotinic acetylcholine receptor knockout mice. | Young JW et al. | β | 2011 | β |
| Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients. | Chen XS et al. | β | 2011 | β |
| Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus. | Zappettini S et al. | β | 2011 | β |
| Effects of progressive muscle relaxation on state anxiety and subjective well-being in people with schizophrenia: a randomized controlled trial. | Vancampfort D et al. | β | 2011 | β |
| Electrophysiological evidence of nicotine's distracter-filtering properties in non-smokers. | Knott V et al. | β | 2011 | β |
| Nicotine ameliorates impairment of working memory in methamphetamine-treated rats. | Mizoguchi H et al. | β | 2011 | β |
| Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention. | Knott VJ et al. | β | 2011 | β |
| Smoking and predictors of nicotine dependence in a homeless population. | Torchalla I et al. | β | 2011 | β |
| Smoking reduces language lateralization: a dichotic listening study with control participants and schizophrenia patients. | Hahn C et al. | β | 2011 | β |
| State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study. | Vancampfort D et al. | β | 2011 | β |
| Strain dependent effects of prenatal stress on gene expression in the rat hippocampus. | Neeley EW et al. | β | 2011 | β |
| The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of Ξ±7*nAChR function. | Araud T et al. | β | 2011 | β |
| Transcriptional repression of the Ξ±7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2Ξ± (AP-2Ξ±). | Finlay-Schultz J et al. | β | 2011 | β |
| Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions. | Rigbi A et al. | β | 2011 | β |
| Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia. | Dulude L et al. | β | 2010 | β |
| Differential effects of nicotinic acetylcholine receptor stimulation on negative occasion setting. | MacLeod JE et al. | β | 2010 | β |
| Differential effects on T-cell function following exposure to serum from schizophrenia smokers. | Herberth M et al. | β | 2010 | β |
| Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. | Mexal S et al. | β | 2010 | β |
| Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. | Knott V et al. | β | 2010 | β |
| Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia. | AncΓn I et al. | β | 2010 | β |
| Factors associated with success of smoke-free initiatives in Australian psychiatric inpatient units. | Lawn S et al. | β | 2010 | β |
| Gender differences in the association between pre-adolescent smoking initiation and emotional or behavioural problems. | de Meer G et al. | β | 2010 | β |
| Individualized smoking cessation treatment in an outpatient setting: Predictors of outcome in a sample with psychiatric and addictions co-morbidity. | Selby P et al. | β | 2010 | β |
| Nicotine dependence and serum BDNF levels in male patients with schizophrenia. | Zhang XY et al. | β | 2010 | β |
| Pharmacological strategies for enhancing cognition in schizophrenia. | Barch DM | β | 2010 | β |
| Premorbid tobacco smoking is associated with later age at onset in schizophrenia. | Ma X et al. | β | 2010 | β |
| Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. | Petrovsky N et al. | β | 2010 | β |
| Smoking modulates language lateralization in a sex-specific way. | Hahn C et al. | β | 2010 | β |
| Smoking, nicotine and neuropsychiatric disorders. | Dome P et al. | β | 2010 | β |
| Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition. | Kozink RV et al. | β | 2010 | β |
| The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. | Kim SH et al. | β | 2010 | β |
| The influence of tobacco consumption on the relationship between schizotypy and hemispheric asymmetry. | Herzig DA et al. | β | 2010 | β |
| Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. | Stephens SH et al. | β | 2009 | β |
| Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors. | Grinevich VP et al. | β | 2009 | β |
| CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance. | Petrovsky N et al. | β | 2009 | β |
| CNTRICS final task selection: long-term memory. | Ragland JD et al. | β | 2009 | β |
| Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status. | Rabin RA et al. | β | 2009 | β |
| Differentiating nicotine- versus schizophrenia-associated decreases of the alpha7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytes. | Severance EG et al. | β | 2009 | β |
| Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. | Zhang T et al. | β | 2009 | β |
| Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity. | Ettinger U et al. | β | 2009 | β |
| Khantzian's 'self-medication hypothesis' of drug addiction and films by Martin Scorsese. | Sivapalan H | β | 2009 | β |
| Nicotine self-medication of cognitive-attentional processing. | Evans DE et al. | β | 2009 | β |
| Positive effects of nicotine on cognition: the deployment of attention for prospective memory. | Rusted JM et al. | β | 2009 | β |
| Predictors of starting to smoke cigarettes in patients with first episode psychosis. | Smith GN et al. | β | 2009 | β |
| Relationship of opioid dependence and positive and negative symptoms in schizophrenic patients. | Ghaffarinejad A et al. | β | 2009 | β |
| Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. | Young JW et al. | β | 2009 | β |
| Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. | Lisman JE et al. | β | 2008 | β |
| Effects of nicotine on quinpirole- and dizocilpine (MK-801)-induced sensorimotor gating impairments in rats. | Nespor AA et al. | β | 2008 | β |
| Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism. | Rasmussen BA et al. | β | 2008 | β |
| Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population. | Kishi T et al. | β | 2008 | β |
| High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. | Dyer MA et al. | β | 2008 | β |
| Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics. | Zhang XY et al. | β | 2008 | β |
| Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. | Kenney JW et al. | β | 2008 | β |
| Nicotine aerosol generation from thermally reversible zinc halide complexes using the Staccato system. | Simis K et al. | β | 2008 | β |
| Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. | Hong LE et al. | β | 2008 | β |
| Nicotine effects on retrieval-induced forgetting are not attributable to changes in arousal. | Rusted JM et al. | β | 2008 | β |
| Novel alpha7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia. | Severance EG et al. | β | 2008 | β |
| Prenatal restraint stress differentially modifies basal and stimulated dopamine and noradrenaline release in the nucleus accumbens shell: an 'in vivo' microdialysis study in adolescent and young adult rats. | Silvagni A et al. | β | 2008 | β |
| Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors. | Zhong C et al. | β | 2008 | β |
| Prospective memory or prospective attention: physiological and pharmacological support for an attentional model. | Marchant NL et al. | β | 2008 | β |
| Reduced auditory evoked potential component N100 in schizophrenia--a critical review. | Rosburg T et al. | β | 2008 | β |
| Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. | Barr AM et al. | β | 2008 | β |
| Sensitization to nicotine significantly decreases expression of GABA transporter GAT-1 in the medial prefrontal cortex. | Pickering C et al. | β | 2008 | β |
| [Smoking and schizophrenia: epidemiological and clinical features]. | Dervaux A et al. | β | 2008 | β |
| The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. | Barr RS et al. | β | 2008 | β |
| Tobacco, alcohol and cannabis use in Tunisian patients with schizophrenia. | Laqueille X et al. | β | 2008 | β |
| Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. | Chen YJ et al. | β | 2008 | β |
| Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder. | Thoma P et al. | β | 2008 | β |
| Characteristics of smokers with a psychotic disorder and implications for smoking interventions. | Baker A et al. | β | 2007 | β |
| Chronic nicotine doses down-regulate PDE4 isoforms that are targets of antidepressants in adolescent female rats. | Polesskaya OO et al. | β | 2007 | β |
| Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. | Weiss S et al. | β | 2007 | β |
| Health habits of patients with schizophrenia. | Roick C et al. | β | 2007 | β |
| Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. | Davis JA et al. | β | 2007 | β |
| Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. | Phillips JM et al. | β | 2007 | β |
| Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia. | Montoya ID et al. | β | 2007 | β |
| Molecular targets for treating cognitive dysfunction in schizophrenia. | Gray JA et al. | β | 2007 | β |
| Neurotensin agonists: potential in the treatment of schizophrenia. | Boules M et al. | β | 2007 | β |
| Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia. | Tizabi Y | β | 2007 | β |
| Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls. | Esterberg ML et al. | β | 2007 | β |
| Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. | Zhang XY et al. | β | 2007 | β |
| Nicotine effects on mismatch negativity in nonsmoking schizophrenic patients. | Inami R et al. | β | 2007 | β |
| Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. | Weiss S et al. | β | 2007 | β |
| Nicotine use and its correlates in patients with psychosis. | Levander S et al. | β | 2007 | β |
| Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison. | Rycroft N et al. | β | 2007 | β |
| Overview of the pharmacogenomics of cigarette smoking. | Ho MK et al. | β | 2007 | β |
| Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors. | Hogg RC et al. | β | 2007 | β |
| Schizophrenia, hypocretin (orexin), and the thalamocortical activating system. | Lambe EK et al. | β | 2007 | β |
| Smoking, Genetics and Schizophrenia: Evidence for Self Medication. | Leonard S et al. | β | 2007 | β |
| Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. | Bouvrais-Veret C et al. | β | 2007 | β |
| Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission. | Wang D et al. | β | 2007 | β |
| Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model. | Wang D et al. | β | 2007 | β |
| The pipeline and future of drug development in schizophrenia. | Gray JA et al. | β | 2007 | β |
| [Tobacco and schizophrenia: therapeutic aspects]. | Dervaux A et al. | β | 2007 | β |
| Tobacco smoking in Egyptian schizophrenia patients with and without obsessive-compulsive symptoms. | Fawzi MH et al. | β | 2007 | β |
| A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. | Postma P et al. | β | 2006 | β |
| Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. | Weaver MF et al. | β | 2006 | β |
| Changes in the amplitude and timing of the hemodynamic response associated with prepulse inhibition of acoustic startle. | Goldman MB et al. | β | 2006 | β |
| Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding. | Chess AC et al. | β | 2006 | β |
| Methodological and conceptual issues in functional magnetic resonance imaging: applications to schizophrenia research. | Brown GG et al. | β | 2006 | β |
| Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study. | Kumari V et al. | β | 2006 | β |
| Nicotine administration enhances conditioned inhibition in rats. | MacLeod JE et al. | β | 2006 | β |
| Nicotine and nonnicotine factors in cigarette addiction. | Rose JE | β | 2006 | β |
| The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine. | Rycroft N et al. | β | 2006 | β |